Skip to main content

Peer Review reports

From: WSG ADAPT – adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial

Original Submission
17 May 2013 Submitted Original manuscript
25 Jul 2013 Reviewed Reviewer Report - Daniel Sargent
5 Aug 2013 Author responded Author comments - Daniel Hofmann
Resubmission - Version 2
5 Aug 2013 Submitted Manuscript version 2
7 Aug 2013 Editorially accepted
19 Aug 2013 Article published 10.1186/1745-6215-14-261

You can find further information about peer review here.

Back to article page